A Receptor-Binding Domain-Based Nanoparticle Vaccine Elicits Durable Neutralizing Antibody Responses Against SARS-CoV-2 and Variants of Concern
EMERGING MICROBES & INFECTIONS(2023)
Key words
Nanoparticle vaccine,SARS-CoV-2,COVID-19,durable antibody response,cross-protectivity,variants of concern
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined